Anthony P. Bihl III

Director at Meridian Bioscience

Anthony Bihl brings more than 35 years of leadership experience across the global medical device market. He was Chief Executive Officer of Bioventus LLC from December 2013 until his retirement in April 2020. He was Group President of American Medical Systems (AMS), a subsidiary of Endo Pharmaceuticals, from June 2011 through June 2012, and President & CEO and Director of AMS from April 2008 until Endo acquired the company in June 2011. He served as Chief Executive Officer of Siemens Medical Solutions’ Diagnostics from January to November 2007, and prior to that held various leadership roles in his six years in the Diagnostics Division of Bayer HealthCare, including serving as President from 2004 to 2006. Mr. Bihl is Chairman of the Board of Directors of Spectral Medical, Inc., a member of the Board of Directors of Sonendo Inc., and a member of the Board of Directors of the Arthritis Foundation.

Timeline

  • Director

    Current role